From: Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia
Trial number | Phase | Study period | Duration of follow-up | Route | Treatment |
---|---|---|---|---|---|
NCT00883870 | 1 and 2 | April 2009 to Dec. 2011 | 6 months | IM | Ex vivo-cultured adult allogeneic MSCs versus plasmalyte A |
NCT00616980 | 1 and 2 | Dec. 2007 to Aug. 2010 | 6 months | IM | Autologous CD34+ cells |
NCT00919958 | 1 | June 2009 to June 2010 | 3 months | IM | Allogeneic PLX-PAD |
NCT00951210 | 1 | Aug. 2009 to Oct. 2011 | 3 months | IM | Allogeneic PLX-PAD |
NCT01049919 | 1 and 2 | June 2010 to May 2014 | 52 weeks | IM | Autologous concentrated BM aspirate using MarroStim PAD kit |
NCT00468000 | 2 | April 2007 to March 2011 | 12 months | IM | Autologous BM cells |
NCT00987363 | 1 and 2 | July 2009 to Dec. 2011 | 12 months | IA | Autologous BM-MNCs in DM |
NCT01019681 | 1 | Nov. 2009 to Nov. 2015 | 24 months | IM | Umbilical cord blood stem cells |
NCT00872326 | 1 and 2 | Dec. 2007 to May 2009 | 3 months | IA | Autologous BM-MNCs |
NCT00523731 | 1 | Jan. 2006 to March 2007 | 3 months | IM | Autologous, non-mobilized angiogenic cell precursor |
NCT00392509 | 1 and 2 | Oct. 2006 to Dec. 2008 | 6 months | IM | Aldehyde dehydrogenase bright stem and progenitor Cell |
NCT01079403 | 1 and 2 | Dec. 2009 to Dec. 2011 | 12 months | IA | Autologous adipose tissue-derived MSCs |
NCT00498069 | 1 and 2 | Nov. 2007 to Jan. 2014 | 5 years | IM | Autologous BM aspirate |
NCT00922389 | 1 and 2 | July 2009 to Jan. 2011 | 12 months | IM | G-CSF + PB MNCs |
NCT00913900 | 1 | May 2009 to Sept. 2012 | 6 months | IM | Autologous CD133+ cells |
NCT00371371 | 1 and 2 | Sept. 2006 to July 2013 | 6 months | IA | Autologous BM-MNCs |
NCT00721006 | 2 | Sept. 2006 to Dec. 2010 | 4 months | SC (40×) | Combination of stem cell therapy |
NCT01065337 | 2 | Oct. 2004 to Feb. 2009 | 12 months | IM/IA | Autologous BM-MNCs versus tissue repair cell CD90+ cells |
NCT00533104 | 1 and 2 | Oct. 2004 to Feb. 2009 | 6 months | IM (30×) | Autologous PB-MNCs and BM-MNCs |
NCT00595257 | 1 and 2 | Dec. 2007 to Aug. 2010 | 60 days | IM | Autologous BM aspirate using SmartPREP2 BMACs |
NCT00434616 | 2 and 3 | April 2007 to July 2011 | 3 months | IM | Autologous BM cell concentrate |
NCT00904501 | 3 | March 2009 to June 2014 | 6 months | IM | Autologous BM-MNCs |
NCT00488020 | 1 | April 2006 to June 2007 | 6 months | IM (40×) | Autologous BM-MNCs |
NCT00518401 | 1 | June 2007 to Oct. 2009 | 6 months | IM (40×) | Combination of stem cell mixture |
NCT00221143 | 1 and 2 | Nov. 2003 to Jan. 2008 | 12 weeks | IM (40×) | Autologous PB CD34 cells |
NCT00539266 | 2 and 3 | Oct. 2007 to Oct. 2010 | 1 year | IM | Autologous BM-MNCs (DM versus non-DM) |
NCT00145262 | 2 | Started in Aug. 2003 | 24 weeks | IM | Autologous BM-MNCs |
NCT00282646 | 1 and 2 | Oct. 2005 to March 2011 | 6 months | IA | Autologous BM-MNCs |